CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+3.81%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$119M
AUM Growth
+$119M
(-4.3%)
Cap. Flow
-$6.38M
Cap. Flow
% of AUM
-5.36%
Top 10 Holdings %
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11
Top Buys
| 1 |
Incyte
INCY
|
$1.71M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$1.63M |
| 3 |
Baidu
BIDU
|
$1.58M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$1.51M |
| 5 |
Alibaba
BABA
|
$1.45M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$14.8M |
| 2 |
National Healthcare
NHC
|
$2.77M |
| 3 |
TAST
Carrols Restaurant Group, Inc.
TAST
|
$2.76M |
| 4 |
Freeport-McMoran
FCX
|
$2.13M |
| 5 |
BGC Group
BGC
|
$1.94M |
Sector Composition
| 1 | Healthcare | 42.71% |
| 2 | Industrials | 9.53% |
| 3 | Technology | 8.54% |
| 4 | Materials | 8.18% |
| 5 | Consumer Staples | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tejon Ranch
TRC
$468M
| $693K | 0.58% |
45,000
+5,000
| +13% | +$77.1K |
|
52
Femasys
FEMY
$13M
| $620K | 0.52% |
400,000
-50,000
| -11% | -$77.5K |
|
53
Compass Therapeutics
CMPX
$474M
| $614K | 0.52% |
310,000
+185,000
| +148% | +$366K |
|
54
Lantern Pharma
LTRN
$43.5M
| $572K | 0.48% |
65,000
-15,000
| -19% | -$132K |
|
55
Elicio Therapeutics
ELTX
$172M
| $570K | 0.48% |
75,000
+25,000
| +50% | +$190K |
|
|
VRNA
56
Verona Pharma
VRNA
$9.16B
| $563K | 0.47% |
+35,000
| New | +$563K |
|
57
First Financial Corporation Common Stock
THFF
$699M
| $537K | 0.45% |
+14,000
| New | +$537K |
|
58
Bristow Group
VTOL
$1.11B
| $418K | 0.35% |
+15,377
| New | +$418K |
|
59
Gain Therapeutics
GANX
$68.7M
| $339K | 0.29% |
90,000
| – | – |
|
60
Assertio
ASRT
$76.4M
| $331K | 0.28% |
345,000
| – | – |
|
61
Eledon Pharmaceuticals
ELDN
$153M
| $330K | 0.28% |
160,000
+20,000
| +14% | +$41.2K |
|
|
KRON
62
DELISTED
Kronos Bio
KRON
| $325K | 0.27% |
250,000
| – | – |
|
63
Cognition Therapeutics
CGTX
$179M
| $319K | 0.27% |
+175,000
| New | +$319K |
|
64
Cadence Bank
CADE
$7.01B
| $290K | 0.24% |
10,000
| – | – |
|
65
BioCardia
BCDA
$11.5M
| $285K | 0.24% |
700,000
| – | – |
|
66
Edesa Biotech
EDSA
$16.3M
| $260K | 0.22% |
62,000
| – | – |
|
67
Smith Micro Software
SMSI
$15.5M
| $207K | 0.17% |
600,000
| – | – |
|
68
Cartesian Therapeutics
RNAC
$261M
| $199K | 0.17% |
305,482
-394,518
| -56% | -$256K |
|
|
PVLA
69
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $105K | 0.09% |
575,000
-175,000
| -23% | -$32.1K |
|
70
APA Corp
APA
$8.53B
| – | – |
-25,000
| Closed | -$897K |
|
|
71
Freeport-McMoran
FCX
$64.5B
| – | – |
-50,000
| Closed | -$2.13M |
|
72
Fidelity National Information Services
FIS
$35.7B
| – | – |
-17,500
| Closed | -$1.05M |
|
73
Fidelity National Financial
FNF
$16.3B
| – | – |
-25,000
| Closed | -$1.28M |
|
|
74
National Healthcare
NHC
$1.76B
| – | – |
-30,000
| Closed | -$2.77M |
|
75
Vital Energy
VTLE
$717M
| – | – |
-15,000
| Closed | -$682K |
|